1.
|
Phase: Phase III Type: Treatment Status: Closed Age: 30 and over Sponsor: Protocol IDs: PVSG-10
|
|
2.
|
Phase: Phase III Type: Supportive care, Treatment Status: Completed Age: no age specified Sponsor: Protocol IDs: PVSG-2
|
|
3.
|
Phase: Phase III Type: Treatment Status: Completed Age: no age specified Sponsor: NCI Protocol IDs: GOG-46, GOG-7862
|
|
4.
|
Phase: Phase III Type: Treatment Status: Closed Age: over 35 Sponsor: Protocol IDs: MRC-LEUK-PRV, EU-92019, UICC-73057, UKM-MRC-PT-7357
|
|
5.
|
Phase: Phase III Type: Treatment Status: Completed Age: 18 to 75 Sponsor: NCI Protocol IDs: GOG-95, MAYO-876102, NCCTG-876102, NCI-87-C-12, SWOG-9047, NCI-T87-0051N, T87-0051
|
|
6.
|
Phase: Phase III Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: GOG-0093, NCCTG-896151
|
|
7.
|
Phase: Phase III Type: Treatment Status: Closed Age: no age specified Sponsor: NCI Protocol IDs: EST-3476
|
|
8.
|
Phase: Phase II, Phase I Type: Treatment Status: Closed Age: 18 and over Sponsor: Protocol IDs: CH/UMC-9210, NCI-V94-0454
|
|
9.
|
Phase: Phase II, Phase I Type: Treatment Status: Closed Age: 21 and over Sponsor: Other Protocol IDs: CMM-99025, NCI-V00-1585, NCT00005939
|
|
10.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: Other Protocol IDs: CMM-95079, CH/UMC-95079, NCI-V95-0760, NCT00002689
|
|
11.
|
Phase: Phase II Type: Treatment Status: Closed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: BIOSP 202, NCT00247260
|
|
12.
|
Phase: Phase I Type: Treatment Status: Closed Age: Over 18 Sponsor: Other Protocol IDs: CMM-99003, NCI-V00-1586, NCT00006212
|
|
13.
|
Phase: No phase specified Type: Treatment Status: Closed Age: 21 and over Sponsor: Protocol IDs: PVSG-5
|
|
14.
|
Phase: No phase specified Type: Treatment Status: Closed Age: 18 and over Sponsor: Other Protocol IDs: USFPG-6034, NCT00079365
|